Early Detection of Nasopharyngeal Carcinoma
Author(s) -
Keiji Tabuchi,
Masahiro Nakayama,
Bungo Nishimura,
Kentarō Hayashi,
Akira Hara
Publication year - 2011
Publication title -
international journal of otolaryngology
Language(s) - English
Resource type - Journals
eISSN - 1687-921X
pISSN - 1687-9201
DOI - 10.1155/2011/638058
Subject(s) - nasopharyngeal carcinoma , medicine , histopathology , malignancy , epidemiology , stage (stratigraphy) , head and neck , disease , oncology , pathology , basal cell , nasopharyngeal cancer , radiation therapy , surgery , biology , paleontology
Nasopharyngeal carcinoma (NPC) is a unique disease with a clinical presentation, epidemiology, and histopathology differing from other squamous cell carcinomas of the head and neck. NPC is an Epstein-Barr virus-associated malignancy with a marked racial and geographic distribution. Specifically, it is highly prevalent in southern China, Southeast Asia, and the Middle East. To date, most NPC patients have been diagnosed in the advanced stage, but the treatment results for advanced NPC are not satisfactory. This paper provides a brief overview regarding NPC, with the focus on the early detection of initial and recurrent NPC lesions.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom